+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Biomedical and ICT Convergence Market by Technology, Solution and Region 2022 - 2027 - Product Thumbnail Image

Biomedical and ICT Convergence Market by Technology, Solution and Region 2022 - 2027

  • Report
  • November 2022
  • 138 Pages
  • Global
From
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 1663 Pages
  • Global
From
Breast Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Breast Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 100 Pages
  • Global
From
France CAR-T Cell Therapy Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

France CAR-T Cell Therapy Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 90 Pages
  • France
From
Germany CAR-T Cell Therapy Market, By Region, Competition, Forecast and Opportunities, 2018-2028F - Product Thumbnail Image

Germany CAR-T Cell Therapy Market, By Region, Competition, Forecast and Opportunities, 2018-2028F

  • Report
  • November 2023
  • 81 Pages
  • Germany
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Cystic Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Cystic Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • October 2023
  • 698 Pages
  • Global
From
CAR T-cell Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

CAR T-cell Therapy - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Japan CAR-T Cell Therapy Market, Competition, Forecast & Opportunities, 2028 - Product Thumbnail Image

Japan CAR-T Cell Therapy Market, Competition, Forecast & Opportunities, 2028

  • Report
  • October 2023
  • 81 Pages
  • Japan
From
United States CAR-T Cell Therapy Market by Product Type, Tumor Type, Indication, Treatment Type, Targeted Antigen, End-user, Region, Competition Forecast & Opportunities, 2028 - Product Thumbnail Image

United States CAR-T Cell Therapy Market by Product Type, Tumor Type, Indication, Treatment Type, Targeted Antigen, End-user, Region, Competition Forecast & Opportunities, 2028

  • Report
  • July 2023
  • 78 Pages
  • United States
From
T-Cell therapy Market By Therapy Type, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

T-Cell therapy Market By Therapy Type, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • May 2023
  • 274 Pages
  • Global
From
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 1699 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1182 Pages
  • Global
From
Biotechnology Market by Technology (Cell-Based Assays, Chromatography, DNA Sequencing), Application (Bioinformatics, Food & Agriculture, Health) - Cumulative Impact of High Inflation - Forecast 2023-2030 - Product Thumbnail Image

Biotechnology Market by Technology (Cell-Based Assays, Chromatography, DNA Sequencing), Application (Bioinformatics, Food & Agriculture, Health) - Cumulative Impact of High Inflation - Forecast 2023-2030

  • Report
  • March 2024
  • 241 Pages
  • Global
From
CAR T-Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

CAR T-Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 111 Pages
  • Global
From
Autologous Cell Therapy Market Report and Forecast 2024-2032 - Product Thumbnail Image

Autologous Cell Therapy Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • September 2024
  • 193 Pages
  • Global
From
Pulmonary Arterial Hypertension Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Pulmonary Arterial Hypertension Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 111 Pages
  • Global
From
Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World - Product Thumbnail Image

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

  • Report
  • November 2023
  • 63 Pages
  • Global
Loading Indicator